Anastomosis Device Market: Market Size & Forecast 2026

The anastomosis device market encompasses a range of surgical tools designed to connect blood vessels, intestinal segments, or other tubular anatomical structures during operative procedures. The sector is experiencing robust expansion, with a projected trajectory from $1.97 billion in 2025 toward $5.15 billion by 2030, sustained by a 21.2% compound annual growth rate. This growth occurs within the broader general surgery devices segment, which is valued at $14.75 billion globally, creating a supportive ecosystem for specialized anastomotic technologies.

• •Market valued at approximately $1.97 billion in 2025, with projections reaching $5.15 billion by 2030 at a 21.2% CAGR
• •Encompasses surgical staplers, suturing devices, anastomotic couplers, and emerging intraluminal protection systems
• •Operates within the broader $14.75 billion global general surgery devices market

The market is propelled by multiple converging forces, including the rising global volume of surgical procedures, particularly in bariatric and colorectal surgery. Clinical evidence demonstrating superior patient outcomes, such as reduced anastomotic leak rates, with powered and advanced devices supports premium pricing and adoption. Additionally, regulatory shifts toward more rigorous FDA Premarket Approval pathways have established higher barriers to entry, favoring established manufacturers with comprehensive clinical trial programs.

• •Increasing global surgical caseloads, especially in bariatric, colorectal, and cardiovascular procedures
• •Clinical data showing improved safety profiles and reduced leak complications with powered versus manual devices
• •Growing preference for sutureless and automated anastomosis platforms supported by systematic review evidence

The market is segmented by product type into surgical staplers (linear and circular), suturing devices, anastomotic couplers, and emerging intraluminal protection and magnetic compression systems. Geographically, North America leads due to advanced healthcare infrastructure, FDA regulatory oversight, and high adoption rates of novel technologies, while the Asia-Pacific region is emerging as a significant growth market driven by expanding surgical volumes and improving healthcare access.

• •Product segmentation includes surgical staplers, suturing devices, anastomotic couplers, and intraluminal protection technologies
• •North America dominates as the primary regional market supported by FDA-regulated device approvals and clinical innovation
• •Asia-Pacific represents a high-growth regional segment driven by rising surgical procedure volumes

What are the recent trends and outlook?

The market is witnessing a clear shift toward sutureless anastomosis technologies, with multiple platforms demonstrating commercial performance and growing adoption rates based on clinical trial evidence. Regulatory requirements continue to evolve, with FDA oversight increasingly favoring comprehensive premarket approval submissions over 510(k) pathways for novel anastomosis devices. Looking ahead, the convergence of artificial intelligence, precision surgical systems, and endoscopic bariatric technologies is expected to drive further market consolidation and product differentiation through 2030.

• •Sutureless anastomosis platforms are gaining clinical and commercial traction, supported by systematic review evidence across multiple device types
• •FDA regulatory pathway is shifting toward Premarket Approval requirements, raising evidentiary standards for market entry
• •AI-guided and intelligent anastomosis systems represent emerging innovation trends anticipated through 2030